Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 12,436 | 72,092 | 13,398 | 3,335 | 12,926 |
| Cost of Goods | 600 | N/A | N/A | N/A | N/A |
| Gross Profit | 11,836 | 72,092 | 13,398 | 3,335 | 12,926 |
| Operating Expenses | 772,025 | 645,273 | 382,761 | 225,439 | 115,553 |
| Operating Income | -759,589 | -573,181 | -369,363 | -222,104 | -102,627 |
| Other Income | 19,230 | -5,304 | 11,426 | 8,848 | 4,209 |
| Pre-tax Income | -740,359 | -578,485 | -357,937 | -213,256 | -98,418 |
| Income Tax | 508 | 3,299 | N/A | N/A | N/A |
| Net Income Continuous | -740,867 | -581,784 | -357,937 | -213,256 | -98,418 |
| Net Income | $-740,867 | $-581,784 | $-357,937 | $-213,256 | $-98,418 |
| EPS Basic Total Ops | -13.18 | -11.21 | -7.96 | -5.69 | -3.19 |
| EPS Basic Continuous Ops | -13.18 | -11.21 | -7.96 | -5.69 | -3.19 |
| EPS Diluted Total Ops | -13.18 | -11.21 | -7.96 | -5.69 | -3.19 |
| EPS Diluted Continuous Ops | -13.18 | -11.21 | -7.96 | -5.69 | -3.19 |
| EPS Diluted Before Non-Recurring Items | -13.18 | -11.21 | -7.96 | -5.69 | -3.19 |
| EBITDA(a) | $-760,860 | $-566,698 | $-369,396 | $-225,276 | $-103,772 |